483 Jari PHarmaceutical Apr 2016

483 Jari PHarmaceutical Apr 2016

Milva Melendez FDA, Teresa Navas FDA$119.00 - Available Now

FDA investigators audited the Jari PHarmaceutical - Lianyungang, China facility and issued inspectional observations (via FDA 483) on 21 Apr 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 21 Apr 2016
  • Location: Lianyungang, China
  • FEI: 3009128843
Add To Cart